a goat was inoculated by intramuscular injection with lysed hiv viral cocktail and formulated with freunds adjuvant . the virus was previously heat killed at 60 ° c . for 30 minutes . blood samples were drawn after an appropriate interval , such as two weeks , for initial assessment . in the optimised procedure , the goat is injected every week for four weeks , then at six weeks the animal is bled to obtain the reagent . approximately 400 cc of blood is drawn from the goat under sterile technique . the area for needle extraction is shaved and prepared with betadine . an 18 - gage needle is used to draw approximately 400 cc of blood from the animal . of note is that the animal can tolerate approximately 400 cc of blood drawn without the animal suffering any untoward effects , the animal does not have to be sacrificed . the animal can then be re - bled in approximately 10 to 14 days after it replenishes its blood volume . the presence of potentially useful antibodies was confirmed , having regard to the desired antibody activity . once the presence of such reagents was confirmed , blood was then taken from the goat at between 4 - 6 weeks . the base blood product in order to create the reagent is then centrifuged to create the serum , 300 ml of serum was then filtered to remove large clots and particulate matter . the serum was then treated with supersaturated ammonium sulphate ( 45 % solution to room temperature ), to precipitate antibodies and other material . the resulting solution was centrifuged at 5000 rpm for five minutes , after which the supernatant fluid was removed . the precipitated immunoglobulin was resuspended in phosphate - buffered saline ( pbs buffer , see sambrook et al , ‘ molecular cloning : a laboratory manual ’, 1989 ) sufficient to redissolve the precipitate . the solution was then dialysed through a membrane with a molecular weight cut off of 10 , 000 daltons . dialysis was carried out in pbs buffer , changed every four hours over a period of 24 hours . dialysis was carried out at 4 ° c . after 24 hours of dialysis the contents of the dialysis bag were emptied into a sterile beaker . the solution was adjusted such that the mass per unit volume = 10 mg per ml . the dilution was carried out using pbs . the resulting solution was then filtered through a 0 . 2 micron filter into a sterile container . after filtration , the solution was aliquoted into single dosages of 1 ml and stored at − 22 ° c . prior to use . a 1 ml aliquot of serum , prepared as described , is injected intramuscularly to a mammalian subject . the treatment is repeated daily for seven days . domestic pets ( canines and felines ) have been treated with the serum at doses ranging from 0 . 04 to 1 . 3 mg / kg ( dogs ), and from 0 . 14 to 1 . 2 mg / kg ( cats ). no significant side effects have been reported . summaries of the treatments are as follows . twelve dogs treated as primary complaint , four other dogs had as a secondary problem . five animals have been reported as significantly improved , five have shown no response ( including three treated for other problems ), and two were ambiguous . one animal was withdrawn by owner , and one the owner reports no longer has bad days . five animals treated as primary complaint , three others as secondary problem . six animals reported as significantly improved or condition resolved ( including two treated for other problems ). one animal with pancreatitis enormously improved in demeanour after a single injection , but continued to vomit . five animals treated as primary complaint , two others as secondary problem . five reported as significantly improved including the two treated for other problems . four domestic dogs were treated with the serum . summaries of their conditions and responses are as follows . primary condition for treatment : chronic lick lesions over both carpii and right pes apparently associated with degenerative joint disease . concurrent active conditions and treatments : polyarthropathy with bilateral carpal varus due to degenerative joint disease . apparent response to treatment : after two injections owner left lick lesion uncovered and dog has not licked at since . concurrent active conditions and treatments : multiple generalised sebaceous cysts that dog chews at . inflammatory bowel disease — dietary management and protexin . occasional injection of dexadreson to manage acute flare up . however extended steroid treatment ( inhaled or tablet ) results in marked side effects . chronic allergic respiratory disease — responds to antihistamine and inhaled steroids apparent response to treatment : over the course of one months treatment with serum noticeable improvement in condition of skin and coat . decreased inflammation associated with generalised sebaceous cysts . since treatment no episodes of inflammatory bowel disease has occurred . on stopping antihistamine the respiratory signs recurred despite treatment . primary condition for treatment : progressive alopecia with borderline low thyroid levels ( awaiting skin biopsy results ). concurrent active conditions and treatments : upper respiratory noise especially when excited , no evidence of collapsing trachea . concurrent active conditions and treatments : persistently elevated alt and alkp but despite investigation no cause of this has been identified . adverse reactions : after first injection on returning home , owner reports hyperexcitable and running around house .
methods for veterinary treatment of mammals are described , for treatment of conditions having an inflammatory component . the methods are particularly suited to treatment of cats , dogs , or horses .